Oppenheimer Maintains Outperform on UnitedHealth Group, Raises Price Target to $405

Benzinga Newsdesk www.benzinga.com Positive 90.7%

Neg 0% Neu 0% Pos 90.7%

Oppenheimer analyst Michael Wiederhorn maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $385 to $405.